Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Clinical Ophthalmology (Auckland, N.Z.)|June 18, 2020
Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service DeliveryWinfried Amoaku, Clare Bailey, Louise Downey, et al.
Molecular Vision|May 19, 2012
Genome-wide association study of primary open angle glaucoma risk and quantitative traitsJane Gibson, Helen Griffiths, Gabriella De Salvo, et al.
Indian Journal of Ophthalmology|June 22, 2026
Diagnostic performance of multiple artificial intelligence (AI) algorithms for diabetic retinopathy screening in primary care: Evidence from real-world settings in IndiaAnshul Chauhan, Gursimran Rana, Priyanka Verma, et al.
Eye (London, England)|March 22, 2022
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practiceIan Pearce, Winfried Amoaku, Clare Bailey, et al.
JAMA Ophthalmology|April 5, 2014
TBK1 gene duplication and normal-tension glaucomaRobert Ritch, Ben Darbro, Geeta Menon, et al.
Eye (London, England)|February 21, 2025
Factors associated with achieving various visual acuity outcomes during loading doses of aflibercept 2 mg for treatment naïve exudative age-related macular degeneration: PRECISE Study Report 7Swati Chandak, Sarega Gurudas, Raheeba Mohammed Pakeer, et al.
JMIR Medical Informatics|September 9, 2025
Real-World Evaluation of AI-Driven Diabetic Retinopathy Screening in Public Health Settings: Validation and Implementation StudyMona Duggal, Anshul Chauhan, Vishali Gupta, et al.
Eye (London, England)|May 12, 2025
Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6Swati Chandak, Sarega Gurudas, Raheeba Pakeer Muhammed, et al.
Eye (London, England)|May 6, 2024
Impact of treat and extend criteria on proportions that can be extended after loading phase of 2 mg aflibercept therapy for neovascular age related macular degeneration: PRECISE Report 5Sridevi Thottarath, Sarega Gurudas, Swati Chandak, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
UNITED KINGDOM DATABASE STUDY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX) FOR MACULAR EDEMA RELATED TO RETINAL VEIN OCCLUSIONMohamed Kamel Soliman, Javier Zarranz-Ventura, Usha Chakravarthy, et al.
Pageof 6